Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study
Titel:
Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study
Auteur:
Kang, Hye Jin Kim, Won Seog Kim, Seok Jin Lee, Je-Jung Yang, Deok-Hwan Kim, Jin Seok Lee, Se-Ryeon Lee, Gyeong-Won Kim, Hyo Jung Kim, Ho Young Oh, Sung Yong Kim, Hugh Chul Eom, Hyeon-Seok Chung, Jooseop Park, Jinny Suh, Cheolwon Ryoo, Baek-Yeol